ANI To Divest Two And Agree To Other Provisions To Close Novitium Deal

Proposed Merger Anticipated To Close This Month Following FTC Settlement

Before closing its acquisition of fellow US-based manufacturer Novitium Pharma, ANI Pharmaceuticals must agree to several orders, including divestment of rights and/or assets for two generic products.

WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.
Prasco is to purchase the generic products from ANI • Source: Shutterstock

More from Deals

More from Business